Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page
- Check3 days agoChange DetectedThe revision label in the documentation section was updated from v3.6.6 to v3.7.0. This reflects a new revision of the study documents.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe revision line now shows Revision: v3.6.6, replacing Revision: v3.6.5. This indicates an updated version of the study documents or related materials associated with the page.SummaryDifference0.0%

- Check24 days agoChange DetectedA line noting an NIH grant/contract funding source was added to the study details, clarifying the source of support for this risankizumab maintenance trial.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a small internal update to the page. It does not modify the study details, eligibility criteria, or results information, and seems to be an internal versioning change.SummaryDifference0.0%

- Check59 days agoChange DetectedFooter now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a minor version update of the page's documentation and does not alter study details or content.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page's revision label in the footer was updated from v3.6.0 to v3.6.3, indicating a newer build/version of the page.SummaryDifference0.0%

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.